Centinel Spine
Private Company
Total funding raised: $50M
Overview
Centinel Spine is a leader in the spinal motion preservation sector, specializing in total disc replacement devices. Its core strength lies in the prodisc® platform, which features a 'Match-the-Disc' system offering multiple implant designs to suit specific patient anatomy and surgeon preference, supported by its proprietary pro disc® CORE articulating technology. The company holds significant FDA approvals, including for two-level use in both the cervical and lumbar spine, differentiating it in the market. As a private entity, it operates in the commercial stage with a direct sales model for its approved medical devices.
Technology Platform
The prodisc® CORE ball-and-socket articulating technology and the 'Match-the-Disc' Platform™, which offers multiple total disc replacement implant designs with various endplates, footprints, and heights to match patient anatomy and surgeon preference.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Centinel Spine competes in the total disc replacement segment against major spine companies like Medtronic (Prestige LP, Maverick), Johnson & Johnson (DePuy Synthes: Charité, ProDisc-L legacy), and Zimmer Biomet (Mobi-C). Its key differentiator is its focused 'Match-the-Disc' portfolio for both cervical and lumbar applications, offering multiple implant options within a single platform.